MK-677 (Ibutamoren) 10 mg Pellets

MK-677 (Ibutamoren) 10 mg Pellets contain ibutamoren, also known as MK-677 and MK-0677. FDA substance records identify ibutamoren by CAS number 159634-47-6, while ibutamoren mesylate is identified separately as CAS 159752-10-0.

Ibutamoren has been investigated as an experimental compound and has been studied in connection with growth-hormone secretion. FDA records state that ibutamoren is not a component of an FDA-approved drug, and an FDA orphan-drug designation for growth hormone deficiency does not constitute FDA approval.

Product Information

• Compound: Ibutamoren (MK-677)
• Alternative designation: MK-0677
• Form: Pellets
• Nominal amount: 10 mg per pellet
• CAS: 159634-47-6
• Research status: Investigational compound

Research & Analytical Use

MK-677 has been investigated in scientific research concerning the growth-hormone/IGF-1 axis. This product listing is intended strictly for legitimate laboratory, analytical and research purposes and should not be represented as an approved medicine, dietary supplement or treatment.

Researchers should verify the product’s identity, purity, analytical documentation and suitability for their specific research protocol before use.

Storage & Handling

Store according to the manufacturer’s documentation and applicable laboratory chemical-handling procedures. Keep the product properly labelled, securely stored and protected from unauthorized access.

Compliance Notice

For laboratory research and analytical purposes only. Not for human or veterinary consumption.

MK-677/ibutamoren is not FDA-approved, and FDA has identified safety concerns associated with ibutamoren mesylate.

Customers and research institutions are responsible for determining whether the product can legally be purchased, possessed, imported, stored or used in their jurisdiction. Applicable requirements may vary between countries.